Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1235

1.

Artificial immunoglobulin light chain with potential to associate with a wide variety of immunoglobulin heavy chains.

Xue H, Sun L, Fujimoto H, Suzuki T, Takahashi Y, Ohnishi K.

Biochem Biophys Res Commun. 2019 Jul 30;515(3):481-486. doi: 10.1016/j.bbrc.2019.05.149. Epub 2019 Jun 2.

2.

Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancer.

Hiroshima Y, Fukumitsu N, Saito T, Numajiri H, Murofushi KN, Ohnishi K, Nonaka T, Ishikawa H, Okumura T, Sakurai H.

Radiother Oncol. 2019 Apr 6;136:37-43. doi: 10.1016/j.radonc.2019.03.012. [Epub ahead of print]

3.

Specific reconstruction on pRC plasmid to facilitate its universal chromosomal integration in different Ralstonia solanacearum species complex strains.

Zhang Y, Gao S, Ohnishi K.

Mol Plant Microbe Interact. 2019 Apr 8. doi: 10.1094/MPMI-01-19-0004-LE. [Epub ahead of print]

PMID:
30958087
4.

Sesamin Catechol Glucuronides Exert Anti-inflammatory Effects by Suppressing Interferon β and Inducible Nitric Oxide Synthase Expression through Deconjugation in Macrophage-like J774.1 Cells.

Abe-Kanoh N, Kunimoto Y, Takemoto D, Ono Y, Shibata H, Ohnishi K, Kawai Y.

J Agric Food Chem. 2019 Apr 16. doi: 10.1021/acs.jafc.8b07227. [Epub ahead of print]

PMID:
30951310
5.

Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing.

Sun L, Kono N, Toh H, Xue H, Sano K, Suzuki T, Ainai A, Orba Y, Yamagishi J, Hasegawa H, Takahashi Y, Itamura S, Ohnishi K.

J Vis Exp. 2019 Mar 15;(145). doi: 10.3791/58804.

PMID:
30933062
6.

Mycoplasma genitalium Infection and Chronic Inflammation in Human Prostate Cancer: Detection Using Prostatectomy and Needle Biopsy Specimens.

Miyake M, Ohnishi K, Hori S, Nakano A, Nakano R, Yano H, Ohnishi S, Owari T, Morizawa Y, Itami Y, Nakai Y, Inoue T, Anai S, Torimoto K, Tanaka N, Fujii T, Furuya H, Rosser CJ, Fujimoto K.

Cells. 2019 Mar 2;8(3). pii: E212. doi: 10.3390/cells8030212.

7.

Volumetric modulated arc therapy with robust optimization for larynx cancer.

Miura H, Doi Y, Ozawa S, Nakao M, Ohnishi K, Kenjo M, Nagata Y.

Phys Med. 2019 Feb;58:54-58. doi: 10.1016/j.ejmp.2019.01.012. Epub 2019 Jan 25.

PMID:
30824150
8.

Functional Characterization of Two Putative DAHP Synthases of AroG1 and AroG2 and Their Links With Type III Secretion System in Ralstonia solanacearum.

Zhang W, Li J, Shi X, Hikichi Y, Zhang Y, Ohnishi K.

Front Microbiol. 2019 Feb 12;10:183. doi: 10.3389/fmicb.2019.00183. eCollection 2019.

9.

Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system.

Kizaki M, Takahashi N, Iriyama N, Okamoto S, Ono T, Usui N, Inokuchi K, Nakaseko C, Kurokawa M, Sumi M, Nakamura F, Kawaguchi T, Suzuki R, Yamamoto K, Ohnishi K, Matsumura I, Naoe T; New TARGET investigators.

Int J Hematol. 2019 Apr;109(4):426-439. doi: 10.1007/s12185-019-02613-1. Epub 2019 Feb 14.

PMID:
30762219
10.

Phase II study of FLAGM (fludarabine + high-dose cytarabine + granulocyte colony-stimulating factor + mitoxantrone) for relapsed or refractory acute myeloid leukemia.

Hatsumi N, Miyawaki S, Yamauchi T, Takeshita A, Komatsu N, Usui N, Arai Y, Ishida F, Morii T, Kano Y, Ogura M, Machida S, Nishii K, Honda S, Ohnishi K, Naoe T; Japan Adult Leukemia Study Group (JALSG).

Int J Hematol. 2019 Apr;109(4):418-425. doi: 10.1007/s12185-019-02606-0. Epub 2019 Feb 6.

PMID:
30725360
11.

Randomized study of imatinib for chronic myeloid leukemia: comparing standard dose escalation with aggressive escalation.

Miyamura K, Ohnishi K, Ohtake S, Usui N, Nakaseko C, Fujita H, Fujisawa S, Sakura T, Okumura H, Iriyama N, Emi N, Fujimaki K, Honda S, Miyazaki Y, Naoe T.

Blood Adv. 2019 Feb 12;3(3):312-319. doi: 10.1182/bloodadvances.2018025981.

12.

Regulation of α-Klotho Expression by Dietary Phosphate During Growth Periods.

Fukuda-Tatano S, Yamamoto H, Nakahashi O, Yoshikawa R, Hayashi M, Kishimoto M, Imi Y, Yamanaka-Okumura H, Ohnishi K, Masuda M, Taketani Y.

Calcif Tissue Int. 2019 Jun;104(6):667-678. doi: 10.1007/s00223-019-00525-0. Epub 2019 Jan 23.

PMID:
30671592
13.

Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae ST258 isolated from a Japanese patient without a history of foreign travel - a new public health concern in Japan: a case report.

Ainoda Y, Aoki K, Ishii Y, Okuda K, Furukawa H, Manabe R, Sahara T, Nakamura-Uchiyama F, Kurosu H, Ando Y, Fujisawa M, Hoshino H, Arima H, Ohnishi K.

BMC Infect Dis. 2019 Jan 7;19(1):20. doi: 10.1186/s12879-018-3649-9.

14.

Preoperative predictive factors focused on inflammation-, nutrition-, and muscle-status in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomy.

Itami Y, Miyake M, Tatsumi Y, Gotoh D, Hori S, Morizawa Y, Iida K, Ohnishi K, Nakai Y, Inoue T, Anai S, Tanaka N, Shimada K, Hirao S, Fujimoto K.

Int J Clin Oncol. 2019 May;24(5):533-545. doi: 10.1007/s10147-018-01381-y. Epub 2019 Jan 2.

PMID:
30604161
15.

Evaluation of a non-prime site substituent and warheads combined with a decahydroisoquinolin scaffold as a SARS 3CL protease inhibitor.

Ohnishi K, Hattori Y, Kobayashi K, Akaji K.

Bioorg Med Chem. 2019 Jan 15;27(2):425-435. doi: 10.1016/j.bmc.2018.12.019. Epub 2018 Dec 12.

PMID:
30558861
16.

High CD169 expression in lymph node macrophages predicts a favorable clinical course in patients with esophageal cancer.

Takeya H, Shiota T, Yagi T, Ohnishi K, Baba Y, Miyasato Y, Kiyozumi Y, Yoshida N, Takeya M, Baba H, Komohara Y.

Pathol Int. 2018 Dec;68(12):685-693. doi: 10.1111/pin.12736. Epub 2018 Dec 5.

PMID:
30516869
17.

Development of endogenous promoters that drive high-level expression of introduced genes in the model diatom Phaeodactylum tricornutum.

Watanabe Y, Kadono T, Kira N, Suzuki K, Iwata O, Ohnishi K, Yamaguchi H, Adachi M.

Mar Genomics. 2018 Dec;42:41-48. doi: 10.1016/j.margen.2018.06.003. Epub 2018 Jun 28.

PMID:
30509379
18.

Dual benefit of supplementary oral 5-aminolevulinic acid to pelvic radiotherapy in a syngenic prostate cancer model.

Miyake M, Tanaka N, Hori S, Ohnishi S, Takahashi H, Fujii T, Owari T, Ohnishi K, Iida K, Morizawa Y, Gotoh D, Itami Y, Nakai Y, Inoue T, Anai S, Torimoto K, Aoki K, Fujimoto K.

Prostate. 2019 Mar;79(4):340-351. doi: 10.1002/pros.23740. Epub 2018 Nov 18.

PMID:
30450646
19.

Contribution of a lectin, LecM, to the quorum sensing signalling pathway of Ralstonia solanacearum strain OE1-1.

Hayashi K, Kai K, Mori Y, Ishikawa S, Ujita Y, Ohnishi K, Kiba A, Hikichi Y.

Mol Plant Pathol. 2019 Mar;20(3):334-345. doi: 10.1111/mpp.12757. Epub 2018 Nov 6.

PMID:
30312504
20.

Dystrophic epidermolysis bullosa pruriginosa presenting with flagellate scarring lesions.

Morimoto N, Shimizu A, Hattori M, Kuriyama Y, Nakano H, Ohnishi K.

Clin Exp Dermatol. 2019 Mar;44(2):e5-e6. doi: 10.1111/ced.13803. Epub 2018 Oct 4. No abstract available.

PMID:
30288768
21.

Targeted proteome analysis of microalgae under high-light conditions by optimized protein extraction of photosynthetic organisms.

Toyoshima M, Sakata M, Ohnishi K, Tokumaru Y, Kato Y, Tokutsu R, Sakamoto W, Minagawa J, Matsuda F, Shimizu H.

J Biosci Bioeng. 2019 Mar;127(3):394-402. doi: 10.1016/j.jbiosc.2018.09.001. Epub 2018 Sep 28.

PMID:
30274798
22.

ATP/P2X7 receptor signaling as a potential anti-inflammatory target of natural polyphenols.

Nuka E, Ohnishi K, Terao J, Kawai Y.

PLoS One. 2018 Sep 24;13(9):e0204229. doi: 10.1371/journal.pone.0204229. eCollection 2018.

23.

Ultrasound-guided intranodal lymphangiography with lipiodol for treatment of chylous ascites following surgery for ovarian cancer: A case report.

Nakamura K, Nakayama K, Minamoto T, Ishibashi T, Ohnishi K, Yamashita H, Ono R, Sasamori H, Razia S, Kamrunnahar S, Ishikawa M, Kyo S.

Mol Clin Oncol. 2018 Aug;9(2):178-180. doi: 10.3892/mco.2018.1647. Epub 2018 Jun 8.

24.

Prognostic significance of pre-treatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in non-surgically treated uterine cervical carcinoma.

Nakamura K, Nakayama K, Tatsumi N, Minamoto T, Ishibashi T, Ohnishi K, Yamashita H, Ono R, Sasamori H, Razia S, Kamrunnahar S, Ishikawa M, Kyo S.

Mol Clin Oncol. 2018 Aug;9(2):138-144. doi: 10.3892/mco.2018.1646. Epub 2018 Jun 5.

25.

A validated proton beam therapy patch-field protocol for effective treatment of large hepatocellular carcinoma.

Nakamura M, Fukumitsu N, Kamizawa S, Numajiri H, Nemoto Murofushi K, Ohnishi K, Aihara T, Ishikawa H, Okumura T, Tsuboi K, Sakurai H.

J Radiat Res. 2018 Sep 1;59(5):632-638. doi: 10.1093/jrr/rry056.

26.

Normal liver tissue change after proton beam therapy.

Fukumitsu N, Takahashi S, Okumura T, Ishida T, Murofushi KN, Ohnishi K, Aihara T, Ishikawa H, Tsuboi K, Sakurai H.

Jpn J Radiol. 2018 Sep;36(9):559-565. doi: 10.1007/s11604-018-0757-9. Epub 2018 Jul 6.

PMID:
29980916
27.

R-High-CHOP/CHASER/LEED with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDY.

Ogura M, Yamamoto K, Morishima Y, Wakabayashi M, Tobinai K, Ando K, Uike N, Kurosawa M, Gomyo H, Taniwaki M, Nosaka K, Tsukamoto N, Shimoyama T, Fukuhara N, Yakushijin Y, Ohnishi K, Miyazaki K, Sawada K, Takayama N, Hanamura I, Nagai H, Kobayashi H, Usuki K, Kobayashi N, Ohyashiki K, Utsumi T, Kumagai K, Maruyama D, Ohmachi K, Matsuno Y, Nakamura S, Hotta T, Tsukasaki K; Japan Clinical Oncology Group- Lymphoma Study Group (JCOG-LSG).

Cancer Sci. 2018 Sep;109(9):2830-2840. doi: 10.1111/cas.13719. Epub 2018 Jul 28.

28.

Possible antithrombotic effects of Angelica keiskei (Ashitaba).

Ohkura N, Atsumi G, Ohnishi K, Baba K, Taniguchi M.

Pharmazie. 2018 Jun 1;73(6):315-317. doi: 10.1691/ph.2018.8370. Review.

PMID:
29880082
29.

Preoperative tumor size is associated with deep myometrial invasion and lymph node metastases and is a negative prognostic indicator for patients with endometrial carcinoma.

Nakamura K, Nakayama K, Ishikawa N, Minamoto T, Ishibashi T, Ohnishi K, Yamashita H, Ono R, Sasamori H, Razia S, Hossain MM, Kamrunnahar S, Ishikawa M, Kyo S.

Oncotarget. 2018 May 1;9(33):23164-23172. doi: 10.18632/oncotarget.25248. eCollection 2018 May 1.

30.

Simulation study of dosimetric effect in proton beam therapy using concomitant boost technique for unresectable pancreatic cancers.

Fukumitsu N, Okumura T, Hiroshima Y, Ishida T, Numajiri H, Murofushi KN, Ohnishi K, Aihara T, Ishikawa H, Tsuboi K, Sakurai H.

Jpn J Radiol. 2018 Jul;36(7):456-461. doi: 10.1007/s11604-018-0743-2. Epub 2018 May 10.

PMID:
29748836
31.

Ashitaba (Angelica Keiskei) Exudate Prevents Increases in Plasminogen Activator Inhibitor-1 Induced by Obesity in Tsumura Suzuki Obese Diabetic Mice.

Ohta M, Fujinami A, Oishi K, Kobayashi N, Ohnishi K, Ohkura N.

J Diet Suppl. 2019;16(3):331-344. doi: 10.1080/19390211.2018.1458366. Epub 2018 Apr 30.

PMID:
29708806
32.

Lynch Syndrome-Related Clear Cell Carcinoma of the Cervix: A Case Report.

Nakamura K, Nakayama K, Minamoto T, Ishibashi T, Ohnishi K, Yamashita H, Ono R, Sasamori H, Razia S, Hossain MM, Kamrunnahar S, Ishikawa M, Ishikawa N, Kyo S.

Int J Mol Sci. 2018 Mar 25;19(4). pii: E979. doi: 10.3390/ijms19040979.

33.

Natural compounds that regulate lymph node sinus macrophages: Inducing an anti-tumor effect by regulating macrophage activation.

Fujiwara Y, Saito Y, Shiota T, Cheng P, Ikeda T, Ohnishi K, Takeya M, Komohara Y.

J Clin Exp Hematop. 2018;58(1):17-23. doi: 10.3960/jslrt.17032.

34.

CD169-positive sinus macrophages in the lymph nodes determine bladder cancer prognosis.

Asano T, Ohnishi K, Shiota T, Motoshima T, Sugiyama Y, Yatsuda J, Kamba T, Ishizaka K, Komohara Y.

Cancer Sci. 2018 May;109(5):1723-1730. doi: 10.1111/cas.13565. Epub 2018 Apr 14.

35.

Angiosarcoma arising in a traumatic scar.

Hattori M, Ohnishi K.

J Dermatol. 2018 Sep;45(9):e244-e245. doi: 10.1111/1346-8138.14285. Epub 2018 Mar 6. No abstract available.

PMID:
29512179
36.

MAP4K3 mediates amino acid-dependent regulation of autophagy via phosphorylation of TFEB.

Hsu CL, Lee EX, Gordon KL, Paz EA, Shen WC, Ohnishi K, Meisenhelder J, Hunter T, La Spada AR.

Nat Commun. 2018 Mar 5;9(1):942. doi: 10.1038/s41467-018-03340-7.

37.

Impact of moral sensitivity on moral distress among psychiatric nurses.

Ohnishi K, Kitaoka K, Nakahara J, Välimäki M, Kontio R, Anttila M.

Nurs Ethics. 2018 Jan 1:969733017751264. doi: 10.1177/0969733017751264. [Epub ahead of print]

PMID:
29495931
38.

The SEC14 phospholipid transfer protein regulates pathogen-associated molecular pattern-triggered immunity in Nicotiana benthamiana.

Kiba A, Nakano M, Ohnishi K, Hikichi Y.

Plant Physiol Biochem. 2018 Apr;125:212-218. doi: 10.1016/j.plaphy.2018.02.002. Epub 2018 Feb 5.

PMID:
29475087
39.

[A Case of Pathological Complete Response Following Neoadjuvant Chemotherapy with Gemcitabine plus Nab-Paclitaxel in Borderline Resectable Pancreatic Cancer].

Ohno N, Ishida M, Ohnishi K, Sawai K, Tabata S, Deguchi M, Kitajima T, Kaizaki Y.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1735-1738. Review. Japanese.

PMID:
29394759
40.

Detection of human papillomavirus in actinic keratosis.

Kuriyama Y, Shimizu A, Ohnishi K, Ishikawa O.

J Dermatol. 2018 Jul;45(7):e183-e184. doi: 10.1111/1346-8138.14239. Epub 2018 Jan 31. No abstract available.

PMID:
29383738
41.

A questionnaire survey of pharmacists regarding the clinical practice guidelines for the appropriate use of granulocyte-colony stimulating factors.

Sasaki T, Kato Y, Sato A, Usui N, Baba E, Takano T, Susumu N, Ohnishi K, Nishimoto H, Kiura K.

J Pharm Health Care Sci. 2018 Jan 17;4:2. doi: 10.1186/s40780-018-0098-y. eCollection 2018.

42.

A putative LysR-type transcriptional regulator PrhO positively regulates the type III secretion system and contributes to the virulence of Ralstonia solanacearum.

Zhang Y, Li J, Zhang W, Shi H, Luo F, Hikichi Y, Shi X, Ohnishi K.

Mol Plant Pathol. 2018 Jan 24. doi: 10.1111/mpp.12660. [Epub ahead of print]

PMID:
29363870
43.

The impact of stromal Hic-5 on the tumorigenesis of colorectal cancer through lysyl oxidase induction and stromal remodeling.

Omoto T, Kim-Kaneyama JR, Lei XF, Orimo A, Ohnishi K, Yoshihara K, Miyauchi A, Li S, Gao L, Umemoto T, Tanaka J, Nakahara K, Takeya M, Ishida F, Kudo SE, Haraguchi S, Miyazaki T, Miyazaki A.

Oncogene. 2018 Mar;37(9):1205-1219. doi: 10.1038/s41388-017-0033-y. Epub 2017 Dec 15.

PMID:
29242607
44.

PPARδ activation by bexarotene promotes neuroprotection by restoring bioenergetic and quality control homeostasis.

Dickey AS, Sanchez DN, Arreola M, Sampat KR, Fan W, Arbez N, Akimov S, Van Kanegan MJ, Ohnishi K, Gilmore-Hall SK, Flores AL, Nguyen JM, Lomas N, Hsu CL, Lo DC, Ross CA, Masliah E, Evans RM, La Spada AR.

Sci Transl Med. 2017 Dec 6;9(419). pii: eaal2332. doi: 10.1126/scitranslmed.aal2332.

45.

Na+ entry through heteromeric TRPC4/C1 channels mediates (-)Englerin A-induced cytotoxicity in synovial sarcoma cells.

Muraki K, Ohnishi K, Takezawa A, Suzuki H, Hatano N, Muraki Y, Hamzah N, Foster R, Waldmann H, Nussbaumer P, Christmann M, Bon RS, Beech DJ.

Sci Rep. 2017 Dec 5;7(1):16988. doi: 10.1038/s41598-017-17303-3.

46.

CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitis.

Itoh M, Suganami T, Kato H, Kanai S, Shirakawa I, Sakai T, Goto T, Asakawa M, Hidaka I, Sakugawa H, Ohnishi K, Komohara Y, Asano K, Sakaida I, Tanaka M, Ogawa Y.

JCI Insight. 2017 Nov 16;2(22). pii: 92902. doi: 10.1172/jci.insight.92902. eCollection 2017 Nov 16.

47.

Underweight status at diagnosis is associated with poorer outcomes in adult patients with acute myeloid leukemia: a retrospective study of JALSG AML 201.

Harada K, Doki N, Hagino T, Miyawaki S, Ohtake S, Kiyoi H, Miyazaki Y, Fujita H, Usui N, Okumura H, Miyamura K, Nakaseko C, Fujieda A, Nagai T, Yamane T, Sakamaki H, Ohnishi K, Naoe T, Ohno R, Ohashi K.

Ann Hematol. 2018 Jan;97(1):73-81. doi: 10.1007/s00277-017-3156-x. Epub 2017 Dec 2.

PMID:
29196987
48.

Distorted antibody repertoire developed in the absence of pre-B cell receptor formation.

Sun L, Kono N, Shimizu T, Toh H, Xue H, Numata O, Ato M, Itamura S, Ohnishi K.

Biochem Biophys Res Commun. 2018 Jan 1;495(1):1411-1417. doi: 10.1016/j.bbrc.2017.11.171. Epub 2017 Nov 27.

49.

A novel mutation in TRPS1 in a patient with tricho-rhino-phalangeal syndrome type 1, accompanied by vesicoureteral reflux.

Morimoto N, Shimizu A, Ohnishi K, Shimomura Y.

Eur J Dermatol. 2017 Dec 1;27(6):666-667. doi: 10.1684/ejd.2017.3141. No abstract available.

PMID:
29138122
50.

Involvement of NpdA, a Putative 2-Nitropropane Dioxygenase, in the T3SS Expression and Full Virulence in Ralstonia solanacearum OE1-1.

Zhang W, Li J, Tang Y, Chen K, Shi X, Ohnishi K, Zhang Y.

Front Microbiol. 2017 Oct 11;8:1990. doi: 10.3389/fmicb.2017.01990. eCollection 2017.

Supplemental Content

Loading ...
Support Center